Moderna, Inc.
MRNA
$53.57
$1.863.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 646.00M | 973.00M | 114.00M | 86.00M | 938.00M |
| Total Other Revenue | 32.00M | 43.00M | 28.00M | 22.00M | 28.00M |
| Total Revenue | 678.00M | 1.02B | 142.00M | 108.00M | 966.00M |
| Cost of Revenue | 1.23B | 1.01B | 819.00M | 946.00M | 1.86B |
| Gross Profit | -549.00M | 8.00M | -677.00M | -838.00M | -895.00M |
| SG&A Expenses | 308.00M | 268.00M | 230.00M | 212.00M | 351.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.54B | 1.28B | 1.05B | 1.16B | 2.21B |
| Operating Income | -857.00M | -260.00M | -907.00M | -1.05B | -1.25B |
| Income Before Tax | -799.00M | -187.00M | -818.00M | -964.00M | -1.18B |
| Income Tax Expenses | 27.00M | 13.00M | 7.00M | 7.00M | -64.00M |
| Earnings from Continuing Operations | -826.00M | -200.00M | -825.00M | -971.00M | -1.12B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -826.00M | -200.00M | -825.00M | -971.00M | -1.12B |
| EBIT | -857.00M | -260.00M | -907.00M | -1.05B | -1.25B |
| EBITDA | -790.00M | -208.00M | -850.00M | -1.01B | -1.19B |
| EPS Basic | -2.11 | -0.51 | -2.13 | -2.52 | -2.91 |
| Normalized Basic EPS | -1.27 | -0.31 | -1.32 | -1.55 | -1.91 |
| EPS Diluted | -2.11 | -0.51 | -2.13 | -2.52 | -2.91 |
| Normalized Diluted EPS | -1.27 | -0.31 | -1.32 | -1.55 | -1.91 |
| Average Basic Shares Outstanding | 392.00M | 390.00M | 388.00M | 386.00M | 385.00M |
| Average Diluted Shares Outstanding | 392.00M | 390.00M | 388.00M | 386.00M | 385.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |